Search

• GSK announces top-line results from pivotal Phase III study of darapladib in chronic coronary heart disease

  Media

  Study did not meet the primary endpoint measure.

  https://www.gsk.com/en-gb/media/press-releases/gsk-announces-top-line-results-from-pivotal-phase-iii-study-of-darapladib-in-chronic-coronary-heart-disease/

  First published: 12 November 2013

• 

  Targeting treatable traits in asthma and other respiratory conditions

  Behind the science magazine

  Targeting certain treatable traits an individual may exhibit could have a significant impact on their quality of life

  https://www.gsk.com/en-gb/behind-the-science-magazine/targeting-treatable-traits-in-asthma-and-other-respiratory-conditions/

  First published: 06 April 2022

• 

  Using new science to get ahead of myelofibrosis - a rare blood cancer

  Behind the science magazine

  Myelofibrosis is a serious blood cancer that involves the build-up of excessive scar tissue in the bone marrow.

  https://www.gsk.com/en-gb/behind-the-science-magazine/using-new-science-to-get-ahead-of-blood-cancer-myelofibrosis/

  First published: 18 November 2022

• 

  ‘Local innovation is vital to our mission to ensure no child is left to suffer from a vaccine preventable disease’

  Behind the science magazine

  Save the Children are looking for local innovators in Ethiopia and Nigeria to help come up with new ways to get vaccines to children in need

  https://www.gsk.com/en-gb/behind-the-science-magazine/child-immunisation-accelerator-comment/

  First published: 23 April 2024

• Regulatory update on US filing plans for closed triple combination therapy FF/UMEC/VI in patients with COPD

  Media

  Acceleration of filing of US New Drug Application now expected by end of 2016

  https://www.gsk.com/en-gb/media/press-releases/regulatory-update-on-us-filing-plans-for-closed-triple-combination-therapy-ffumecvi-in-patients-with-copd/

  First published: 02 June 2016

• GSK’s ECLIPSE study shows association between improving health status and reduced morbidity and mortality in patients with COPD

  Media

  keeping stable health status in patients with COPD significantly reduces the likelihood of exacerbation, hospital admission and dying.

  https://www.gsk.com/en-gb/media/press-releases/gsk-s-eclipse-study-shows-association-between-improving-health-status-and-reduced-morbidity-and-mortality-in-patients-with-copd/

  First published: 18 May 2015

• GSK and the Francis Crick Institute join forces in collaboration to forge new scientific discoveries

  Media

  The Francis Crick Institute and GSK to partner on an innovation collaboration exploring new avenues of medical research and drug discovery

  https://www.gsk.com/en-gb/media/press-releases/gsk-and-the-francis-crick-institute-join-forces-in-collaboration-to-forge-new-scientific-discoveries/

  First published: 14 July 2015

• GSK receives positive CHMP opinion in Europe for novel anti-IL5 biological Nucala (mepolizumab) for the treatment of patients with severe refractory eosinophilic asthma

  Media

  GSK today announced that the CHMP of EMA issued a positive opinion recommending marketing authorisation for mepolizumab

  https://www.gsk.com/en-gb/media/press-releases/gsk-receives-positive-chmp-opinion-in-europe-for-novel-anti-il5-biological-nucala-mepolizumab-for-the-treatment-of-patients-with-severe-refractory-eosinophilic-asthma/

  First published: 24 September 2015

• GSK and MMV announce start of phase III programme of tafenoquine for Plasmodium vivax malaria

  Media

  GSK and Medicines for Malaria Venture (MMV) today announced the start of a phase III global programme.

  https://www.gsk.com/en-gb/media/press-releases/gsk-and-mmv-announce-start-of-phase-iii-programme-of-tafenoquine-for-plasmodium-vivax-malaria/

  First published: 28 April 2014

• GSK and Save the Children offer $1 million award for healthcare innovations in developing countries that reduce child deaths

  Media

  GSK and Save the Children today announced the launch of their second annual $1 million Healthcare Innovation Award.

  https://www.gsk.com/en-gb/media/press-releases/gsk-and-save-the-children-offer-1-million-award-for-healthcare-innovations-in-developing-countries-that-reduce-child-deaths/

  First published: 30 June 2014